Table 1. Non-serious Application Site Adverse Reactions (≥1% VOLTAREN GEL Patients) – Short-term Controlled Trials †Preferred Term according to MedDRA 9.1. Adverse Reaction† VOLTAREN GEL N=913 Placebo (vehicle) N=876 N (%) N (%) Any application site reaction 62 (7) 19 (2...
were application site reactions. These were the only adverse reactions that occurred in >1% of treated patients with a greater frequency in the VOLTAREN GEL group (7%) than the placebo
Shape TRIANGLE (biconvex, triangular-shaped) Size 10mm Flavor Imprint Code VOLTAREN;75 Contains Packaging #Item CodePackage DescriptionMarketing Start DateMarketing End Date 1 NDC:0028-0264-01 100 in 1 BOTTLE Marketing Information Marketing CategoryApplication Number or Monograph CitationMarketing Start...
(NDA) 022122 001 VOLTAREN ARTHRITIS PAIN DICLOFENAC SODIUM 双氯芬酸钠 GEL;TOPICAL 1% HALEON US HOLDINGS 2007-10-17 Yes Yes OTC (NDA) 020037 001 VOLTAREN DICLOFENAC SODIUM 双氯芬酸钠 SOLUTION/DROPS;OPHTHALMIC 0.1% NOVARTIS 1991-03-28 Yes No DISCN (NDA) 019201 001 VOLTAREN DICLOFENAC SOD...